The U.S Food and Drug Administration (FDA) has awarded grants to five research institutes for the study and improvement of biomanufacturing, including 3D bioprinting.

Scott Gottlieb, MD, FDA Commissioner, said, “Advanced manufacturing technologies, such as continuous manufacturing, hold great promise for improvements in the reliability, flexibility, and cost-effectiveness of manufacturing for biological products.”

“We awarded in grants to five globally-recognized research institutions to study ways in which cutting-edge manufacturing technologies can be implemented to advance these goals, and enable more innovative, consistent, and dependable manufacturing of biological products”